CD4 and renal carcinoma: In addition, CD4+ T cells promote renal cancer cell proliferation by regulating YBX1 (Wang et al., 2018), and MDSCs accumulate in various tumors, promoting vascular survival and improving tumor immunity (De Cicco et al., 2020).